6ASP

Structure of Grp94 with methyl 3-chloro-2-(2-(1-(2-ethoxybenzyl)-1 H-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate, a Grp94-selective inhibitor and promising therapeutic lead for treating myocilin-associated glaucoma

Summary for 6ASP

• Entry DOI: 10.2210/pdb6asp/pdb
• Descriptor: Endoplasmin, 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL, GLYCEROL, ... (5 entities in total)
• Functional Keywords: grp94, hsp90, inhibitor, glaucoma, chaperone-inhibitor complex, chaperone/inhibitor
• Biological source: Canis lupus familiaris (Dog); More
• Total number of polymer chains: 2
• Total formula weight: 58969.69

Authors

Huard, D.J.E.,Lieberman, R.L. (deposition date: 2017-08-25, release date: 2018-04-18, Last modification date: 2023-10-04)

• Primary citation: Huard, D.J.E.,Crowley, V.M.,Du, Y.,Cordova, R.A.,Sun, Z.,Tomlin, M.O.,Dickey, C.A.,Koren, J.,Blair, L.,Fu, H.,Blagg, B.S.J.,Lieberman, R.L.; Trifunctional High-Throughput Screen Identifies Promising Scaffold To Inhibit Grp94 and Treat Myocilin-Associated Glaucoma.; ACS Chem. Biol., 13:933-941, 2018; PubMed: 29402077; DOI: 10.1021/acschembio.7b01083

Experimental method

X-RAY DIFFRACTION (2.696 Å)